Johnson and Johnson most productive innovator for 4th consecutive year

Written by LVS on in the category news.

Every year, IDEA pharma presents its productive innovation index. The index ranks biopharmaceutical companies by their ability to bring innovations to the market. To give you an idea of what this practically means, ask yourself the following question: if you gave the same molecule in early phase to different companies, which one of them would make the best of it? Which companies succeed in bringing innovation all the way to the patients?

For the 4th year in a row, the answer according to IDEA pharma is Johnson and Johnson. Their successes in fields as various as oncology, immunology, neurosciences, cardiovascular/metabolism have made them the single most successful innovator in the current market.

Completing the top three are Takeda (2nd place) and Novo Nordisk (3rd place). Interestingly, these companies are extremely high risers, gaining 14 and 15 places, respectively, compared to the 2015 ranking.

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Biowin UGent V-Bio Ventures Janssen GSK KU Leuven XpandInnovation Turnstone Itera Life Science

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via or by completing the contact form.